0102030405
CAS No 705260-08-8 VORAPAXAR SULFATE Pharmaceutical Intermediates
02
Product detail
Product detail
Vorapaxar Sulfate is a selective antagonist of the protease-activated receptor 1 (PAR-1), which plays a crucial role in platelet activation and aggregation. The compound is particularly effective in preventing thrombosis and is a valuable asset in cardiovascular therapy.
- Molecular formula: C29H35FN2O8S
-Molecular weight:590.66 g/mol
- Appearance: white to off-white powder
- Solubility: Soluble in water and organic solvents
- Melting Point: Specific melting point data available upon request
02
product detail
|
CAS No. |
40856-44-8 |
|
EINECS |
609-874-3 |
|
Formula |
C9H11NO2 |
|
Molecular Weight |
165.19 |
|
Appearance |
White to Off-White solid |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
1. Targeted Action: Vorapaxar sulfate specifically inhibits PAR-1, providing a targeted approach for antithrombotic therapy. This selectivity helps minimize the risk of bleeding complications associated with other antiplatelet drugs.
2. Proven efficacy: Clinical studies have shown that Vorapaxar Sulfate can effectively reduce the incidence of cardiovascular events in high-risk patients and is an indispensable component of modern cardiovascular treatment programs.
3. Easy to take: Vorapaxar Sulfate is available in an oral dosage form, which is convenient to take and has a higher patient compliance. This convenience is critical for long-term management of cardiovascular health.
4. Proven Safety: Vorapaxar Sulfate has been extensively clinically tested and its safety has been proven. This reliability is critical for healthcare providers to prescribe anti-thrombotic therapy.
Vorapaxar Sulfate is a breakthrough pharmaceutical compound that plays a vital role in preventing thrombotic cardiovascular events. As a selective antagonist of protease-activated receptor-1 (PAR-1), Vorapaxar Sulfate effectively inhibits platelet activation and aggregation, thereby reducing the risk of heart attack and stroke in high-risk patients.
Our integrated manufacturing and trading facilities are dedicated to providing high-quality Vorapaxar Sulfate that meets the stringent requirements of the pharmaceutical industry. We use advanced manufacturing techniques and adhere to strict quality control procedures to ensure that our products are of the highest purity and potency. Each batch of Vorapaxar Sulfate is rigorously tested to guarantee compliance with industry standards, giving our customers confidence in the quality of our products.
The targeted action of Vorapaxar Sulfate distinguishes it from traditional antiplatelet therapy. By specifically inhibiting PAR-1, the compound minimizes the risk of bleeding complications that may be associated with the use of non-selective antiplatelet drugs. This targeted approach not only improves patient safety, but also improves the overall efficacy of cardiovascular treatment regimens.
Vorapaxar Sulfate has been shown to be effective in clinical trials, showing that it can significantly reduce the rate of cardiovascular events in patients with a history of myocardial infarction or peripheral artery disease. This evidence-based efficacy makes Vorapaxar Sulfate a top choice for healthcare providers seeking to optimize outcomes for their cardiovascular care patients.
In addition to its clinical benefits, Vorapaxar Sulfate also offers a convenient dosing option. The compound is available in an oral formulation that allows for easy administration, which is critical for patients who require long-term antithrombotic therapy. Improving patient compliance is a key factor in the successful management of cardiovascular health, and Vorapaxar Sulfate effectively meets this need.
As a trusted partner to the pharmaceutical industry, our company is committed to providing a reliable supply of Vorapaxar Sulfate. Our strong production capabilities ensure that we can meet our customers' needs while maintaining competitive pricing and timely delivery. We understand the importance of having a reliable supply of critical medications, and we strive to exceed our customers' expectations in every aspect of our service.
In summary, Vorapaxar Sulfate is an essential compound for the prevention of thrombotic cardiovascular events. With its targeted action, proven efficacy, and established safety profile, it is the first choice for healthcare providers. Trust our integrated facility to meet your pharmaceutical needs and experience the difference in quality and service. Contact us today to learn more about Vorapaxar Sulfate and how we can support your pharmaceutical business.